These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4809445)

  • 41. Benign azotemia of long-term hemodialysis: increase in blood urea nitrogen and serum creatinine concentrations after the initiation of dialysis.
    Abuelo JG
    Am J Med; 1989 Jun; 86(6 Pt 1):738-9. PubMed ID: 2729336
    [No Abstract]   [Full Text] [Related]  

  • 42. Changes in insulin binding during hemodialysis in uremic patients.
    Milutinović S; Breyer D; Molnar V; Stefović A; Janković N; Skrabalo Z; Rocić B
    Nephron; 1985; 41(4):307-13. PubMed ID: 3906417
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dialyzable uremic solutes contribute to enhanced oxidation of serum albumin in regular hemodialysis patients.
    Terawaki H; Nakayama K; Matsuyama Y; Nakayama M; Sato T; Hosoya T; Era S; Ito S
    Blood Purif; 2007; 25(3):274-9. PubMed ID: 17460395
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multicentric experience with combined hemodialysis/hemoperfusion in chronic uremia.
    Bonomini V; Stefoni S; Casciani CU; Taccone Gallucci M; Albertazzi A; Cappelli P; Mioli V; Boggi R; Mastrangelo F; Rizzelli S
    Contrib Nephrol; 1982; 29():133-42. PubMed ID: 7075212
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Deficiency of serum ionized magnesium in patients receiving hemodialysis or peritoneal dialysis.
    Markell MS; Altura BT; Sarn Y; Delano BG; Ifudu O; Friedman EA; Altura BM
    ASAIO J; 1993; 39(3):M801-4. PubMed ID: 8268649
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum paraoxonase activity in uremic predialysis and hemodialysis patients.
    Dirican M; Akca R; Sarandol E; Dilek K
    J Nephrol; 2004; 17(6):813-8. PubMed ID: 15593056
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Values of active metabolites of vitamin D in the serum of uremic patients on long-term hemodialysis].
    Stefanović V; Kostić S; Dordević V; Grubor-Lajsić G; Mitić-Zlatković M
    Acta Med Iugosl; 1988; 42(2):81-8. PubMed ID: 3389195
    [No Abstract]   [Full Text] [Related]  

  • 48. Association between uremic toxins and depression in patients with chronic kidney disease undergoing maintenance hemodialysis.
    Hsu HJ; Yen CH; Chen CK; Wu IW; Lee CC; Sun CY; Chang SJ; Chou CC; Hsieh MF; Chen CY; Hsu CY; Tsai CJ; Wu MS
    Gen Hosp Psychiatry; 2013; 35(1):23-7. PubMed ID: 23044245
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
    Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
    G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Factors affecting serum and urinary guanidinosuccinic acid levels in normal and uremic subjects.
    Kopple JD; Gordon SI; Wang M; Swendseid ME
    J Lab Clin Med; 1977 Aug; 90(2):303-11. PubMed ID: 886215
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Satellite hemodialysis.
    Shapiro FL; Messner RP; Smith HT
    Ann Intern Med; 1968 Oct; 69(4):673-84. PubMed ID: 4878809
    [No Abstract]   [Full Text] [Related]  

  • 52. Response to rapid removal of intermediate molecular weight solutes in uremic man.
    Silverstein ME; Ford CA; Lysaght MJ; Henderson LW
    Trans Am Soc Artif Intern Organs; 1974; 20 B():614-21. PubMed ID: 4450311
    [No Abstract]   [Full Text] [Related]  

  • 53. Daytime rhythm and treatment-related fluctuations of serum phosphorus concentration in dialysis patients.
    Viaene L; Meijers B; Vanrenterghem Y; Evenepoel P
    Am J Nephrol; 2012; 35(3):242-8. PubMed ID: 22353750
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Calcium absorption in renal failure: its relationship to blood urea nitrogen, dietary calcium intake, time on dialysis, and other variables.
    Recker RR; Saville PD
    J Lab Clin Med; 1971 Sep; 78(3):380-8. PubMed ID: 5092859
    [No Abstract]   [Full Text] [Related]  

  • 55. [Control by means of Computer control of the hematochemical picture in chronic uremic patients undergoing periodic hemodialysis treatment].
    Novario PG; Pagliano B; Denti E; Segoloni G; Piccoli G; Vercellone A; Coppo R
    Minerva Nefrol; 1974; 21(5):347-59. PubMed ID: 4467056
    [No Abstract]   [Full Text] [Related]  

  • 56. [Calcitonin sensitivity testing in patients with kidney diseases. Changes in serum calcium, phosphorus and plasma cyclic adenosine monophosphate levels under the effect of calcitonin in healthy subjects and uremic patients under chronic hemodialysis].
    Szücs J; Steczek K
    Orv Hetil; 1978 May; 119(20):1220-4. PubMed ID: 206866
    [No Abstract]   [Full Text] [Related]  

  • 57. Serum middle molecule levels in uremia during long term intermittent hemoperfusions with the acac (coated charcoal) microcapsule artificial kidney.
    Chang TM; Migchelsen M; Coffey JF; Stark A
    Trans Am Soc Artif Intern Organs; 1974; 20A():364-71. PubMed ID: 4217485
    [No Abstract]   [Full Text] [Related]  

  • 58. Distribution of calcium in the rat due to chronic renal failure.
    Ellis KJ; Martino A; Yasumura S; Brook D; Cohn SH; Letteri JM
    Nephron; 1977; 18(2):124-31. PubMed ID: 854140
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Circulating somatomedin activity and sulfate levels in adults with normal and impaired kidney function.
    Phillips LS; Kopple JD
    Metabolism; 1981 Nov; 30(11):1091-5. PubMed ID: 7289882
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of hemodialysis on guanidinopropionic acid metabolism.
    Gurreri G; Ghiggeri G; Salvidio G; Garibotto G; Robaudo C; Deferrari G
    Nephron; 1986; 42(4):295-7. PubMed ID: 3960241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.